Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Wealth management is crucial for women looking to grow their assets. Discover expert tips tailored to help women succeed in managing their wealth.
18,468 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Better Home & Finance signs a tokenized funding deal with Framework Ventures to access up to $500 million in credit v...
Investors are watching Micron Technology closely as AI-driven demand reshapes memory markets. This guide explains whe...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...
AMD’s AI accelerator cycle could change the stock picture if the MI350 ramp and MI450 shipments hit on schedule. This...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
When a high-profile investor places big bets in AI leaders, markets take notice. This piece breaks down the latest mo...
This guide dives into credo tech (crdo) 2026 Q3 earnings expectations, key drivers, and how investors can position th...
Cumberland's 2025 earnings signal steady growth and improving margins, with a diversified product mix and a promising...
As AI demand soars, Micron sits at the center of memory hardware used in data centers. This article breaks down wheth...
Long-running dividend growers are showing resilience as 2026 markets churn. AWR and NFG lead a small group with 50+ y...